Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis

Area of Science:

• Gastroenterology and Oncology
• Molecular Biology and Cancer Research

Background:

• Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma.
• Cell cycle proteins are potential biomarkers for BE malignant potential.
• The causal role of cell cycle disruption in BE carcinogenesis remains unclear.

Purpose of the Study:

• To investigate the role of cell cycle disruption in Barrett's carcinogenesis.
• To determine if cell cycle abnormalities contribute to malignant progression in BE.

Main Methods:

• Immunohistochemical staining for cell cycle markers (cyclin D1, A, B1, phosphorylated histone 3).
• Flow cytometric analysis of cell cycle phase distribution in prospective biopsies.
• Analysis of specimens from the Barrett's dysplasia-carcinoma sequence.

Main Results:

• Proliferation in nondysplastic BE extends to the luminal surface.
• Increased proliferation in dysplastic samples correlates with dysplasia grade (P <.001).
• Cyclins A and B1 levels correlate with dysplasia grade (P <.001).
• Cell cycle phase distribution remains conserved across all stages of BE, dysplasia, and cancer.

Conclusions:

• Increased proliferation in Barrett's carcinogenesis stems from abnormal cell cycle entry/exit.
• Primary cell cycle abnormalities are not the cause of increased proliferation.
• Findings suggest dysregulation of cell cycle control rather than intrinsic cell cycle defects.